European technology takeover target

(Full access for Members only)

European technology takeover target

26 April 2019

What readers said about this report

If you can guess the name of the company based on the following bread crumbs, then you won't need to become a Member of this website:

  • EUR 2bn market cap.
  • Liquid stock traded on a major European exchange.
  • Top 3 global market position.
  • Ample cash flow from a well-established operation.
  • Strategic asset desired by the likes of Microsoft or Apple.
  • 31% to 69% upside in the case of a bid.

I expect a bid for this company to come in sometime during the next 12-18 months, or possibly a lot earlier given that there are likely a dozen or so interested parties.

If this sounds like an investment opportunity you'd like to learn more about, read my 30-page research report.

Not a Member yet? Sign up for a Membership - just USD 49/year.
Already a Member? Log into your account to download the report.

|  What readers said about this report

Bernd P.
May 2021

I really like that you take a clear stand - such as with (company name hidden by Undervalued-Shares.com) - even if it's not so positive!!

Thomas N.
July 2019

[...] Thanks to you, I also got into Gazprom (unfortunately too little) and (company name hidden by Undervalued-Shares.com) (unfortunately just after the mega dividend) and can already report some nice book profits on these positions! […]

l  Report updates

Not a Member yet? Sign up for a Membership.
Already a Member? Log into your account to download the report updates.

4 May 2021

Report Update (PDF - 0.2MB)

19 January 2021

Report Update (PDF - 0.2MB)

29 July 2020

Report Update (PDF - 0.1MB)

5 June 2020

Report Update (PDF - 0.1MB)

3 April 2020

Report Update (PDF - 0.1MB)

23 October 2019

Report Update (PDF - 0.8MB)

8 August 2019

Report Update (PDF - 0.1MB)

30 June 2019

Report Update (PDF - 0.4MB)

22 May 2019

Report Update (PDF - 0.1MB)

20 May 2019

Report Update (PDF - 0.2MB)

Most recent

Latest reports (for Members only)

Actinium-225, aka "the world's rarest drug"

Actinium-225, aka "the world's rarest drug"

This little-known Western European company could become the global market leader for supplying the uber-rare "Ac-225", a potent weapon to treat cancer.

Internet leader at a bargain price

Internet leader at a bargain price

If you missed buying Meta or Spotify in 2022, this global Internet leader is for you. One major investor is already on the case.
4x from a deal with Ukraine?

4x from a deal with Ukraine?

If or when Russian securities become fungible again, this stock could move quite quickly – as, indeed, it has already started to do.